▲ Peaking
Business
Adicet Bio CAR-T sparks lupus remissions in early trial as ‘new era’ of autoimmune treatment approaches
Adicet Bio's experimental CAR-T therapy sparks early lupus remissions, drawing widespread industry attention.
Car-T
11 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
Living Drugs Transformed Blood Cancer Treatment—and That’s Just the Beginning
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
◼ Archived
Business
Kyverna ‘resetting conversation’ with 1-year miv-cel data as autoimmune CAR-T peers hit safety snags
Kyverna advances its cell therapy toward an FDA submission as new one-year durability data emerges.
◼ Archived
Business
🔮 fades ✓
Bristol Myers claims Phase 2 success for GPRC5D-directed CAR-T
Bristol Myers Squibb reports successful Phase 2 results for its next-generation GPRC5D-directed CAR-T therapy targeting heavily treated myeloma patients.
◼ Archived
Business
🔮 fades ✓
Bristol Myers' blood cancer cell therapy succeeds in mid-stage trial
Bristol Myers Squibb stock rises as its blood cancer cell therapy succeeds in a mid-stage trial.
◼ Archived
Business
🔮 fades ✗
Novartis, Bristol Myers pause autoimmune CAR-T trials due to safety concerns
Novartis and Bristol Myers Squibb halt autoimmune CAR-T trials following patient deaths, impacting the sector.
◼ Archived
Business
🔮 holds ✓
Three deaths in CAR-T trials prompt halt by Novartis; Bristol Myers programs also paused
Novartis and Bristol Myers Squibb halt multiple CAR-T clinical trials for autoimmune diseases following patient deaths and safety reviews.
◼ Archived
Health
🔮 holds ✗
Cell therapy substantially reduces severe rheumatoid arthritis in first clinical trial
A first-of-its-kind clinical trial demonstrates that CAR T-cell therapy can put severe rheumatoid arthritis into remission.
◼ Archived
Health
🔮 fades ✓
Exclusive: Third death in China's popular but opaque trials revealed, this time in CAR-T
Coverage reveals a third death in opaque Chinese clinical trials involving CAR-T therapy, intensifying global scrutiny.
◼ Archived
Health
🔮 fades
Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
New GPNMB‑CAR‑T therapy shows promise against the deadliest brain cancer, glioblastoma.
◼ Archived
Business
🔮 fades
Moderna enters in vivo CAR-T, granting autoimmune asset ‘007’ license to kill pathogenic cells
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.